C21 Investments Acquires Silver State Relief with CDN $37.5 Million of Revenue in Nevada

Vancouver, British Columbia–(Newsfile Corp. – July 16, 2018) – C21 Investments, Inc., (CSE: CXXI) (the “Company” or “C21“) is pleased to announce a strategic expansion into the State of Nevada with one of the largest investment transactions into the USA cannabis industry by any Canadian public company to date. The acquisition (the “Acquisition”) and investment of expansion capital into Silver State Relief LLC and Silver State Cultivation LLC (Collectively “Silver State”) represents a major investment transaction valuing the acquired vertically integrated assets in excess of USD$50 million. This major acquisition of revenue generating assets of CDN $37.5 million trailing 12-month revenue (USD $28.5 million) is a new milestone in C21’s expansion into the USA cannabis industry. The Silver State transaction is the first transaction in a larger plan by C21 to significantly expand cultivation, processing, wholesale distribution of branded products and retail operations throughout the State of Nevada. The Silver State Nevada partnership will establish C21’s competitive position in the Nevada market. C21’s investment and expansion of Silver State’s operations will generate new high-quality jobs and economic development within the State of Nevada. www.cxxi.ca

President and CEO of C21 Robert Cheney stated: “Our entire C21 leadership is very excited to enter the Nevada market and looks forward to working with our new partners at Silver State. This represents our first acquisition of an established and profitable, vertically integrated business with strong potential for significant expansion on all levels, and is aligned with C21’s long term growth objectives.”

Silver State Acquisition Terms

  1. For consideration to acquire Silver State Cultivation LLC and Silver State Relief LLC, USD$20 million cash payment paid upon closing with an additional 2,500,000 common shares to be granted upon closing.
  2. An interest bearing (3% per annum) convertible note with a principal value of USD$14 million with a term of 36-months from the date of closing, where the principal amount of the note is convertible into common shares of the Company at a price of USD$3.50 per common share of C21. The Company will have an option to acquire the 155,000 square-foot cultivation facility, including the 8,000-square foot retail dispensary building, located in Sparks, Nevada (the “Sparks”), for an acquisition price of USD$16 million or 4,571, 428 common shares at a deemed value of USD$3.50 per share. 
  3. The option to acquire the second dispensary real estate located in Fernley, Nevada (the “Fernley”) for an acquisition price of USD$750,000 for the existing building, land and fixtures, including construction adjustments, with a total estimated cost being approximately USD$2,175,000.
  4. A commitment of USD$10 million allocated for the purpose of further expansion within the State of Nevada.
The closing of the Acquisition is conditional upon due diligence and subject to regulatory approval.

Regarding the new partnership, Sonny Newman, founder and sole owner of Silver State commented; “My team is pleased to become part of the C21 family. The Silver State brands and products are a strong compliment to C21’s existing business, and with the financial strength of C21 we look forward to expanding our reach within Nevada and nationwide.”

About Silver State

Silver State was one of the first two companies to receive a cannabis cultivation, production and retail license in the State of Nevada.  Silver State cultivated and sold Nevada’s first legal ounce of marijuana and the company continues to be a leader in the Nevada industry.  Silver State operates an industrial state-of-the-art indoor cultivation and processing facility of approximately 155,000 square feet of licensed space in Washoe County, Northern Nevada, where there is capacity in the facility to triple current production rates and expand revenues.

Silver State also owns two retail licenses to operate dispensaries in Nevada. Sparks, the first dispensary is located in the city of Sparks, with a second location scheduled to open later this year in the city of Fernley, Lyon County. Sparks is an 8,000 square-foot “cannabis superstore” facility, located in Washoe county, having 21 points of sale and servicing over 36,000 customers per month. The Fernley dispensary license, is an existing licensed building and property, located in an area experiencing rapid economic growth and housing/business development. Fernley is currently under construction and is expected to go into operation in the fourth quarter of 2018. This new retail location along with expanding wholesale operations is anticipated to capture similar revenue of Sparks, with the potential to double revenues over the coming 18 months.

Silver State Revenues

In 2017, Silver State reported approximately USD$17 million of top line revenue and approximately USD$7 Million of pre-tax profit, a year that included less than six months of recreational sales.   In 2018 the revenue for the first six months, as at June 30, 2018 totaled approximately USD$15 million. The 2018 full year revenues are expected to significantly exceed 2017 revenues, with the trailing revenues for the past 12-months totalling USD$28.5 Million (CDN $37.5 Million).  The Sparks dispensary is recorded as one of the top three revenue producing dispensaries in Nevada for the past 36-months in a row.  www.silverstaterelief.com

About C21 Investments

C21 is a cannabis company with newly acquired operations in Oregon, USA. The Company is in active discussions to acquire additional operations in the USA and globally, that allows for C21 to establish a world-class, vertically integrated cannabis company. C21’s strategy is to acquire existing and successful cannabis operations with experienced management teams in place. C21’s focus is to expand into jurisdictions where it can wholly own indoor/outdoor cultivation operations, processing/extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network. C21’s strategy will allow the Company to report top line revenues and afford C21 the ability to compete aggressively in the rapid growth of the cannabis industry. www.cxxi.ca

ON BEHALF OF THE BOARD

SIGNED: “Robert Cheney”

Robert Cheney, CEO, President, Director
For more information contact:
Robert Cheney Tel: (604) 336-8613

Cautionary Statement:

Disclaimer: This press release contains “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information includes, but is not limited to, statements with respect to the Company’s future business operation, expectations of gross sales, the opinions or beliefs of management and future business goals, statements regarding the timing and completion of the listing on the CSE and C21’s USA Acquisitions. Generally, forward looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to general business, economic and competitive uncertainties, regulatory risks including risks related to the expected timing of the Company’s participation in the Adult Use market, market risks, risks inherent in manufacturing operations and other risks of the cannabis industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information. Forward-looking information is provided herein for the purpose of presenting information about management’s current expectations relating to the future and readers are cautioned that such information may not be appropriate for other purpose. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws. This Release does not constitute an offer of securities for sale in the United States, and such securities may not be offered or sold in the United States absent registration or an exemption from registration or an exemption from registration.

The CSE has not accepted responsibility for the adequacy or accuracy of this release, and in no way has passed upon the merits of the Acquisition, nor has it approved or disapproved the contents of this press release.

from Newsfile Corp News Releases https://ift.tt/2JozQS9

Advertisements

iCo Therapeutics Announces Positive Secondary Endpoint and Advancement into Later Stage Clinical Trials – Phase 1 Oral Amphotericin B

Vancouver, British Columbia–(Newsfile Corp. – July 16, 2018) – iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or “the Company”), and its subsidiary iCo Therapeutics Australia Pty Ltd., today announced a positive pharmacokinetic secondary end point in its Phase 1 clinical study. Previously the Company reported that the study met its primary endpoint of safety and tolerability of iCo-019 (Oral Amp B) following oral administration of single ascending doses (4 dose levels) in healthy subjects, including no gastrointestinal events of note. iCo currently expects to present and publish detailed results in a peer reviewed publication once all intellectual property filings have been secured.

Key highlights:

  • The distinguishing features of the Company’s Oral Amp B candidate are enhanced plasma AUC (area under the concentration time curve, which is a measure of systemic drug exposure) and a longer blood circulation time without the associated gastrointestinal effects or liver and kidney toxicity.
  • Mean Cmax (maximum observed concentration), at a single dose, was similar to what other groups have reported.
  • This data implies that an aggressive multiple dose strategy would be feasible.
  • The Company currently intends on studying efficacy in future clinical safety and efficacy studies at dose ranges of 100mg, 200 mg and 400 mg.

Dr. Kishor Wasan, Professor and Dean, College of Pharmacy and Nutrition, University of Saskatchewan, and co-inventor of the technology stated, “Pharmacokinetic and previously reported safety results catapult iCo Therapeutics into a clear leadership position in the race towards the development of an proprietary oral Amphotericin B drug candidate. Clear superiority was achieved in the clinic versus competition at lower doses and iCo Therapeutics has a good sense of doses which may be examined in upcoming later staged clinical studies”.

iCo Therapeutics also wishes to congratulate Dr. Wasan on his recent appointment to Canada’s pre-eminent pharmaceutical school, commencing in 2019. For more information please see the announcement below:

http://www.pharmacy.utoronto.ca/content/announcing-new-dean-and-interim-dean-leslie-dan-faculty-pharmacy

About the Phase 1 Clinical Trial

The Phase 1 Australian study conducted was a randomized, double-masked, placebo-controlled, single dose ascending study to assess the safety, tolerability, and bioavailability of iCo-019 (Oral Amphotericin B) in healthy male and non-pregnant female subjects between 18-55 years of age. Subjects were randomized into one of 4 cohorts, each representing an ascending single dose of treatment. Cohorts were dosed sequentially. Each cohort consisted of eight (8) subjects where six (6) subjects were randomized to receive the Investigational Product (IP) and two (2) subjects were randomized to receive the Placebo. A sentinel group consisting of two subjects (one subject receiving the IP and one subject receiving the Placebo) were dosed before the other subjects in each cohort. All subjects were followed for 7 days after dosing. The safety profile for each subject treated in that cohort were reviewed by the Safety Review Committee (SRC).

About iCo Therapeutics

iCo Therapeutics identifies existing development stage assets for use in underserved ocular and infectious diseases. Such assets may exhibit utility in non-ophthalmic conditions outside the Company’s core focus areas and if so the Company will seek to capture further value via partnerships, such as its license with Immune Pharmaceuticals (NASDAQ: IMNP), which is in Phase 2 involving iCo-008. iCo shares trade on the TSX Venture Exchange under the symbol “ICO” and on the OTCQB under the symbol “ICOTF”.

For more information, visit the Company website at: www.icotherapeutics.com.

No regulatory authority has approved or disapproved the content of this press release. Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Forward-Looking Statements

Certain statements included in this press release may be considered “forward-looking information” within the meaning of applicable securities laws. Forward-looking information can be identified by words such as: “anticipate”, “intend”, “plan”, “goal”, “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on iCo’s current beliefs as well as assumptions made by and information currently available to iCo and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based only on information currently available to iCo and speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by iCo in its public securities filings and on its website, actual events may differ materially from current expectations. iCo disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Mike Liggett
Chief Financial Officer
778 802 9806
liggett@icotherapeutics.com

from Newsfile Corp News Releases https://ift.tt/2zHFFKS

ALX Uranium Corp. Announces Purchase Agreement for the Tango Property in Northern Saskatchewan

Vancouver, British Columbia–(Newsfile Corp. – July 16, 2018) – ALX Uranium Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) (“ALX” or the “Company”) is pleased to announce that the Company has signed an agreement to earn a 100% interest in the Tango Property (“Tango”, or the “Property”) from DG Resource Management Ltd. (the “Vendor”), a private company controlled by a director of ALX. Tango consists of eight claims totaling 13,709 hectares (33,876 acres) prospective for nickel, copper and cobalt mineralization and is located approximately 175 kilometres northwest of La Ronge, Saskatchewan, Canada.

ALX believes that the Tango property has the potential to host polymetallic mineral deposits, based on the results of historical sampling and geological mapping programs. Mineralization found within metasedimentary rocks southwest of Dot Lake, near the center of the Property, has been traced over a length of 2.0 kilometres (1.25 miles).

“Our acquisition of the Tango Property is consistent with our commitment to mineral exploration in Saskatchewan,” said Warren Stanyer, CEO and Chairman of ALX. “Tango could host polymetallic mineralization and we intend to apply leading-edge exploration methods to unlock its full potential.”

ALX’s acquisition of the Tango Property from a company controlled by a director of ALX is a “related party transaction” within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The acquisition is exempt from the valuation and minority shareholder approval requirements of MI 61-101 by virtue of the exemptions contained in section 5.5(a) and 5.7(a) of MI 61-101 in that the fair market value of the consideration paid by ALX to the director’s company does not exceed 25% of ALX’s market capitalization.

Details of the Tango Purchase Agreement

The Vendor has agreed to sell and transfer to ALX an undivided 100% interest in the Property for an initial payment of $20,000 on signing of the purchase agreement (paid), and an additional payment of $20,000 on closing of the transaction (“Closing”), subject to a 2.0% net smelter returns royalty (“NSR”). One-half of the NSR (i.e., 1.0%) can be purchased by ALX for $2.0 million at any time within five years from Closing. The Tango purchase agreement is subject to the acceptance of the TSX Venture Exchange.

About Tango

Tango is located in an underexplored area of the Mudjatik Domain of northern Saskatchewan, where exploration for uranium in the late 1970s discovered showings of gold, nickel, cobalt and copper in surface sampling of outcrops. Airborne electromagnetic surveys detected conductors that were not followed up by diamond drilling when the uranium rush of the era subsided in the early 1980s.

In 1979, Golden Eagle Oil and Gas Ltd. carried out surface prospecting on Tango as part of a wider regional exploration program for uranium and base metals. Lake sediment samples taken by Golden Eagle in the Tango area showed anomalous values of nickel, copper, cobalt and zinc. Grab samples from a historical showing known as the Sunlite Trench returned the following values*:

Sample
Number
Year Gold
(
grams/tonne)
Silver
(
grams/tonne)
Nickel
(%)
Copper
(%)
Cobalt
(%)
RBB 024 1979 5.83 0.10 0.128 0.373 0.260
RBB 25 1979 4.11 0.60 0.193 0.497 0.240
RN 36 1979 3.00 3.60 0.326 0.268 0.499

 

(*Source: Saskatchewan Mineral Deposit Index, Mineral Deposit No. 1043)

In 1980, Golden Eagle re-trenched and re-sampled a gold-bearing quartz vein at the Sunlite Trench and recorded a gold value of 18.0 grams/tonne in a grab sample, along with 0.16% copper. Further work was recommended, but was not carried out and the mineral permit lapsed in 1984. Other precious metals explorers completed surface sampling for gold and follow-up ground geophysical programs, but by 1992 exploration ceased without any drilling having been carried out within the area of the Property.

The technical information in this news release has been reviewed and approved by Sierd Eriks, P.Geo., President and Chief Geologist of ALX, who is a Qualified Person in accordance with the Canadian regulatory requirements set out in National Instrument 43-101. Readers are cautioned that the technical information described in this news release is historical in nature; however, the information is deemed credible and was produced by professional geologists in the years discussed. Historical grab sample values shown in the above table and otherwise discussed were hand-selected and are not indicative of the nature and grade of mineralization over a wide area.

About ALX

ALX’s mandate is to provide shareholders with multiple opportunities for discovery by exploring a portfolio of prospective mineral properties in northern Saskatchewan, Canada. The Company executes well-designed exploration programs using the latest technologies and has interests in over 200,000 hectares in Saskatchewan, a Province which hosts the richest uranium deposits in the world, a producing gold mine, and demonstrates potential for base metals deposits. ALX is based in Vancouver, BC, Canada and its common shares are listed on the TSX Venture Exchange under the symbol “AL”, on the Frankfurt Stock Exchange under the symbol “6LLN” and in the United States OTC market under the symbol “ALXEF”. Technical reports are available on SEDAR at www.sedar.com for several of the Company’s active properties.

For more information about the Company, please visit the ALX corporate website at www.alxuranium.com or contact Roger Leschuk, Manager, Corporate Communications at Ph: 604.629.0293 or Toll-Free: 1.866.629.8368, or by email: rleschuk@alxuranium.com.

On Behalf of the Board of Directors of ALX Uranium Corp.

“Warren Stanyer”

Warren Stanyer, CEO and Chairman

FORWARD LOOKING STATEMENTS

Statements in this document which are not purely historical are forward-looking statements, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include the Company‘s plans to undertake exploration activities at the Tango Property, and use leading leading-edge exploration methods to unlock its full potential. It is important to note that the Company’s actual business outcomes and exploration results could differ materially from those in such forward-looking statements. Risks and uncertainties include that our projects in Saskatchewan, including the Tango Property, may prove to be unworthy of further expenditure; economic, competitive, governmental, environmental and technological factors may affect the Company’s operations, markets, products and prices. We may not have access to or be able to use leading edge technology because of cost factors, type of terrain, or availability of equipment and technology. We may also not raise sufficient funds to carry out our plans. Additional risk factors are discussed in the section entitled “Risk Factors” in the Company’s Management Discussion and Analysis for the Three Months ended March 31, 2018, which is available under Company’s SEDAR profile at www.sedar.com. Except as required by law, we will not update these forward looking statement risk factors.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

from Newsfile Corp News Releases https://ift.tt/2L8Q7zR

Strikepoint Gold Inc. Acquires the High-Grade Silver, Porter Idaho Property in the Golden Triangle, British Columbia

Vancouver, British Columbia–(Newsfile Corp. – July 16, 2018) – StrikePoint Gold Inc. (TSXV: SKP) (OTCQB: STKXF) is pleased to announce, further to its press release on May 2, 2018, “StrikePoint Gold Inc. to Acquire the High-Grade Silver, Porter Idaho Property in the Golden Triangle, British Columbia,” that it has finalized the acquisition with Skeena Resources Limited (TSXV: SKE) of the Porter Idaho Property near Stewart, British Columbia, indirectly through the acquisition of Mount Rainey Silver Inc. (“Mount Rainey”), a wholly owned subsidiary (the “Transaction”).

Highlights

  • Porter Idaho Property has two shear hosted silver-rich vein systems (the historic Silverado and Prosperity-Porter Idaho mines) that are located 2 kilometers apart. Recent glacial retreat has exposed the ground between the two sites for the first time and so the opportunity exists to connect the two deposits.

  • The Porter Idaho Project contains an historical Indicated Resource of 394,700 tonnes grading 868 g/t silver, 3.37% lead and 1.41% zinc (435,000 tons @ 25.2 oz/ton silver or a contained 11 million ounces) and an Inferred Resource of 88,900 tonnes grading 595 g/t silver (97,900 tons @ 17.3 oz/ton silver or a contained 1.7 million ounces).

  • The transaction also includes the Glacier Creek Claims situated 4km to the north of Porter Idaho. These low elevation, road accessible claims have been unexplored for a century, but are adjacent to the historic Dunwell Mine, which produced 9,800 ounces of gold and 329,000 ounces of silver from 50,000 tons of ore between 1926 and 1941.

The Porter Idaho — Silverado Mines

The Porter Idaho Project contains two shear hosted silver-rich vein systems: the Silverado and Prosperity-Porter Idaho. The showings are 2km apart, located on opposite sides of Mt. Rainey, overlooking the town of Stewart. The Project is strategically located at the head of the Portland Canal, a deep-water port with year-round, ice-free access.

Since the initial discovery of silver mineralization on Mt. Rainey in the early 1900’s, most of the work was focused on the Prosperity-Porter Idaho veins, where mineralization is hosted in six dipping parallel shear zones tracked on surface for 200 meters and one kilometer down dip with widths between 2 and 13 meters. The vein system was mined between 1929 and 1931 and produced 27,123 tonnes with recovered grades of 2,542 g/t silver (73.8 oz/ton) and 1 g/t gold (yielding approximately 2.2 million ounces of silver). The ore was shipped to the port at Stewart via aerial tramway.

A two-month period of due diligence work has been completed by Strikepoint technical staff and as such exploration activities will be underway shortly, with a camp established on site before the end of July. Review of historical documents indicate a structural relationship between then Porter Idaho and Silverado historic mine sites and work will focus on bridging these two zones through a combination of mapping and diamond drilling.

Historic Silver Resource

The Porter Idaho Project contains an historical Indicated Resource of 394,700 tonnes grading 868 g/t silver, 3.37% lead and 1.41% zinc (435,000 tons @ 25.2 oz/ton silver or a contained 11 million ounces) and an Inferred Resource of 88,900 tonnes grading 595 g/t silver (97,900 tons @ 17.3 oz/ton silver or a contained 1.7 million ounces).

Figure 1: Porter Idaho Project Historical Resource Estimate

To view an enhanced version of Figure 1, please visit:
http://orders.newsfilecorp.com/files/5044/35972_a1531533440603_14.jpg

Estimates of mineral resources are dated March 10, 2008, and were prepared by independent consulting geologist N.C. Carter, Ph.D., P. Eng. for Raimount Energy Inc. and re-stated for Mount Rainey Silver Inc. on May 15, 2012. The foregoing estimates made use of an extensive database detailing results of both underground sampling programs as well as surface and underground diamond drilling and were prepared pursuant to CIM Standards on Mineral Resources and Reserves. Nevertheless, the reader is cautioned that a Qualified Person on behalf of StrikePoint has not done sufficient work to verify either the underlying sampling data or the calculation methodology to consider this to be a current resource and as a result, StrikePoint is treating this mineral resource as an Historical Estimate, as defined in National Instrument 43-101. StrikePoint has not yet determined what work needs to be completed in order to upgrade or verify the Historical Estimate.

The Transaction

The terms of the Transaction are as follows:

    • $1,500,000 payable in cash to Skeena
    • $250,000 payable within 10 business days closing definitive agreement
    • $250,000 payable December 31, 2018
    • $250,000 payable March 31, 2019
    • $375,000 payable June 30, 2019
    • $375,000 payable December 31, 2019
    • issuance to Skeena of 9,500,000 StrikePoint common shares representing aggregate value of $2,000,000, deemed at a value of $0.21 per share, based upon the 20-day VWAP of StrikePoint’s common shares;

    • grant of 1% NSR on the Property with the option to buy back 0.5% at any time at a price of $750,000.

The Property has a three-year exploration permit in place allowing for exploration work on the site, including surface mapping, sampling and diamond drilling. The permit also allows for the establishment of a 15-person exploration camp on the property.

Additional Assets

The acquisition of Mount Rainey also comes with the Glacier Creek claims situated about four kilometers north. These have a lower average elevation (75-meters above sea level) and are partially road accessible from the highway.

Gold mineralization is hosted in brecciated quartz and quartz carbonate vein systems controlled by north-trending fault and shear zones, with pyrite, sphalerite, galena and silver / gold within sulphides.

The Glacier Creek claims are adjacent to and overlap in some areas the historic Dunwell Mine, which produced 9,800 ounces of gold and 329,000 ounces of silver from 50,000 tons of ore between 1926 and 1941. Sporadic underground sampling was undertaken in the old workings in the 1950’s and the 1980’s, but no surface work has been completed since the discovery in the early 1900’s, and as such have potential for new discoveries.

In addition to the Glacier Creek claims, the transaction also comes with a number of municipal lots in the town of Stewart.

About the Golden Triangle

The Golden Triangle is an area of northwestern British Columbia that has seen extensive historic mining and prospecting activity, and has recently been the site of modern discoveries, including the Premier Gold, Snip and Eskay Creek Mines. The area has seen a resurgence in infrastructure investment which supports exploration activities, including upgraded transmission lines supplying clean, affordable and reliable hydroelectric power. Other recent improvements include highway upgrades, new ocean port infrastructure at the ice-free port of Stewart and the commissioning of three hydroelectric facilities.

StrikePoint Gold is a well-financed gold exploration and development company. The company controls a portfolio of gold properties in the Yukon and throughout Canada.

The technical information contained in this news release has been approved by Andy Randell, P. Geo., Vice President, Exploration of StrikePoint Gold. Mr. Randell is a qualified person as defined in NI 43-101.

For further information please visit our website: www.strikepointgold.com

ON BEHALF OF THE BOARD of STRIKEPOINT GOLD INC.

Shawn Khunkhun
CEO and Director

For more information, contact:
Shawn Khunkhun
604-602-1440
sk@strikepointgold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

from Newsfile Corp News Releases https://ift.tt/2mmoyoB

Tidal Royalty Corp. Announces Listing on United States OTC Market

Toronto, Ontario–(Newsfile Corp. – July 16, 2018) – Tidal Royalty Corp. (CSE: RLTY.U) (OTC: TDRYF) (“Tidal Royalty” or the “Company“), a leading provider of royalty financing to licensed U.S. cannabis operators, announces that the Company has applied for eligibility to The Depository Trust Company (“DTC“) for its shares trading on the OTC Market. DTC is a subsidiary of the Depository Trust & Clearing Corp (“DTCC“) that manages the electronic clearing and settlement of publicly-traded companies in the United States. DTC eligibility will simplify the process of trading and is expected to enhance liquidity of the Company’s common shares on the OTC marketplace, where Tidal Royalty now trades under the symbol “TDRYF”. The Company is optimistic that it will be fully DTC-eligible in the next two weeks.

Tidal Royalty Chairman & CEO Paul Rosen stated: “This visibility on a U.S.-based listing provides us great confidence as we continue to establish our company with the American investment community. Our goal is to graduate Tidal Royalty shares to more senior exchanges as we continue to build our company and as the U.S. cannabis market matures.”

About Tidal Royalty

Tidal Royalty provides royalty financing to the U.S. regulated cannabis industry. Led by an executive team with extensive industry experience in Canada and the U.S., Tidal Royalty provides operators with the funding they need to grow their business. Operators benefit from non-dilutive capital and investors get top-line access to a diversified portfolio of companies that will form the future of this transformative industry.

For further information, please contact:

Tidal Royalty Corp.
Terry Taouss, President
Email: terry@tidalroyalty.com
Phone: 416.710.8377

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Readers are cautioned that forward-looking information contained in this new release is not based on historical facts but instead is based on reasonable assumptions and estimates of management. Forward-looking information contained in this news release includes, but is not limited to: the ability to enter into definitive documentation in respect of letters of intent currently entered into by Tidal Royalty, the ability of Tidal Royalty to enter into additional letters of intent and associated definitive documentation with current or further proposed investee companies, the operating and financial performance of any investee company to be funded by Tidal Royalty from time to time, the ability of Tidal Royalty to generate revenue or realize profit through royalty agreements with any future investee companies, the anticipated use of proceeds from private placements completed by Tidal Royalty and the effectiveness of Tidal Royalty’s Advisory Board in providing strategic advice. Forward-looking information contained herein is based on the opinions and reasonable assumptions and estimates of management as at the date hereof, and is subject to a variety of known and unknown risks and uncertainties and other factors that could cause actual events or results of Tidal Royalty to differ materially from those expressed or implied in the forward-looking information. Such factors include: U.S. regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change, risks relating to anti-money laundering laws and regulation, other governmental and environmental regulation, public opinion and perception of the cannabis industry, risks related to the enforceability of contracts, the requirement by Tidal Royalty to obtain additional financing, the limited operating history of Tidal Royalty, timeliness of government approvals for granting of permits and licences needed by any future investee companies, including licences to cultivate cannabis, the actual operating and financial performance of any future investee company may differ materially from that anticipated by Tidal Royalty, competition and other risks affecting Tidal Royalty in particular and the U.S. cannabis industry generally, and the risk factors effecting Tidal Royalty disclosed in the listing statement of Tidal Royalty available at www.sedar.com. Because of such risks, uncertainties and other factors, investors should not place undue reliance on the forward-looking information contained herein. Tidal Royalty is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. The foregoing statements expressly qualify the forward-looking information contained herein. This release does not constitute an offer for sale of, nor a solicitation for offers to buy, any securities in the United States.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

from Newsfile Corp News Releases https://ift.tt/2zHZamF

SEC Files Charges in Busted Microcap Schemes

Washington, DC–(Newsfile Corp. – July 13, 2018) – The Securities and Exchange Commission has charged a stock promoter and four others involved in an alleged series of microcap fraud schemes that were foiled by FBI undercover work and an SEC trading suspension.

According to the SEC’s complaint filed in federal court in southern California on July 6, stock promoter Gannon Giguiere took control of a purported medical device company. Giguiere, together with a Cayman Islands-based broker, then allegedly engaged in a matched trading scheme that caused the company’s share price to rise from zero to $1.20 per share. Giguiere and the brokerage owner, Oliver-Barret Lindsay, allegedly coordinated their matched trading through an individual who turned out to be an FBI cooperating witness. According to the complaint, despite extensive encrypted communications, the defendants were caught by an undercover FBI operation that recorded their communications, with Lindsay going so far as to tell an individual cooperating with the FBI, “I’m a little hesitant about typing all of these details into this app. … You can just imagine if it finds its way somewhere, it’s fairly incriminating.” According to the complaint, the pair’s plan to dump millions of shares in the purported medical device company was thwarted when, this past March, the SEC suspended trading in the securities of the purported medical device company.

The SEC’s complaint also charges three others who began laying the groundwork for a pump-and-dump scheme involving a purported digital media company. The SEC alleges that Kevin Gillespie, Annetta Budhu and Andrew Hackett entered into a number of sham stock and debt issuances, and Hackett wound up communicating with someone he believed to be a participant in the scheme who in reality was an undercover FBI agent.

“As alleged in our complaint, these stock traders hijacked companies and manipulated the market to enrich themselves at the expense of the investing public. Law enforcement is committed to rooting out microcap fraud and exposing it no matter how encrypted or complex such schemes may be,” said Marc P. Berger, Director of the SEC’s New York Office. 

The U.S. Attorney’s Office for the Southern District of California today announced criminal charges.

The SEC’s investigation, which is continuing, has been conducted by John O. Enright, Joseph P. Ceglio, Diego Brucculeri and Sheldon L. Pollock of the New York office. The SEC’s litigation will be handled by Messrs. Enright and Ceglio. The case is being supervised by Sanjay Wadhwa. The SEC appreciates the assistance of the FBI, U.S. Attorney’s Office for the Southern District of California, and Financial Industry Regulatory Authority.

from Newsfile Corp News Releases https://ift.tt/2zEKFQG

CHC Student Housing Announces Refinancings

Toronto, Ontario–(Newsfile Corp. – July 13, 2018) – CHC Student Housing Corp. (TSXV: CHC) (“CHC” or the “Company”) is pleased to announce the closing of refinancing transactions on its properties in London, Ontario and Trois-Rivières, Québec.

Under the London, Ontario property refinancing, an arm’s length third party has assumed the existing $33.0 million first mortgage on the property, and the first mortgage has been amended to bear interest at a rate of 90 day Bankers Acceptances plus 2.55% (currently 1.85% for a total interest rate of 4.4%), and to have a maturity date of June 30, 2021. Halmont Properties Corporation (“Halmont”) (TSXV: HMT), also an arm’s length third party, has assumed the existing $13.75 million second mortgage on the property, and the second mortgage has been amended to have the principal amount of $14.0 million, to bear interest at a rate of 7%, subject to a right for CHC to defer certain interest payments for a period of 18 months, and to have a maturity date of June 30, 2021. Halmont also has a right under the second mortgage to an additional payment based on growth in net operating income from the property above an agreed threshold during the term of the loan or in the event the property is sold for a value in excess of an agreed value. Proceeds of the refinancing were used to payout the existing first and second mortgage lenders in the aggregate amount of $46.75 million and to pay transaction costs. CHC’s obligations to the lenders under the mortgages is also secured by a second charge over CHC’s student housing property in Trois-Rivières, Québec, and a first charge over all of CHC’s personal property.

In connection with the refinancing transaction on the London property, CHC will issue to Halmont 200,000 non-transferable common share purchase warrants (the “Loan Warrants”), each of which will be exercisable to acquire one common share of CHC at an exercise price $2.00 per share until June 30, 2021. The issuance of the Loan Warrants is subject to the approval of the TSX Venture Exchange.

Under the Trois-Rivières, Québec refinancing, an arm’s length third party has assumed the existing $2.175 million mortgage on the property, and the mortgage has been amended to have the principal amount of $2.57 million, to bear interest at a rate equal to the greater of Royal Bank of Canada’s Prime Rate plus 4.05% or 7.5%, and to have a maturity date of October 1, 2019. Proceeds of the refinancing used to discharge the existing first mortgage on the property of $2.175 million, to pay transaction costs and to finance planned improvements at the property which are expected to be completed by the fall.

“We are very pleased to have been able to complete these refinancing transactions and want to thank our new lenders and in particular Halmont for their support,” stated Simon Nyilassy, President and CEO of CHC. “Completing these refinancings on these terms will enable us to further stabilize the Company as we continue to focus on our objectives in student housing and working to increase shareholder value.”

About CHC Student Housing Corp.

CHC Student Housing Corp. is an owner and operator of student housing properties located in proximity to universities in primary and well understood secondary markets.

Forward Looking Information

Certain statements contained in this news release may constitute forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “anticipate”, “plan”, “expect”, “may”, “will”, “intend”, “should”, and other similar expressions. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Any forward-looking statements contained in this news release represent the Company’s expectations as of the date hereof, and are subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.

Neither the TSX Venture Exchange (“TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Simon Nyilassy, President and Chief Executive Officer
CHC Student Housing Corp.
Telephone: (416) 504-9380
Email: snyilassy@marigoldandassociates.com

from Newsfile Corp News Releases https://ift.tt/2ulC28w